Quercetin-induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in Bad and hypophosphorylated retinoblastoma expressions
The DOI matches its Crossref record.
Abstract
Nasopharyngeal carcinoma is a common cancer in South-East Asia, especially among people of Chinese origin. In this report, we investigate the effects of quercetin on the growth of wild-type and mutant p53 nasopharyngeal carcinoma cell lines, HK1 and CNE2 respectively. The wild-type p53 HK1 was more susceptible to growth inhibition by quercetin than the mutant p53 CNE2. The ID50 values for HK1 and CNE2 were 35.0 and 54.5 microM respectively. Cell growth arrest was initiated by the up-regulation of retinoblastoma gene expression, resulting in cell cycle arrest in either the G2/M or G0/G1 phase at 14.8 and 52.1 microM quercetin respectively regardless of the p53 status. Flow cytometry experiments revealed that quercetin-induced apoptosis during the first 24 h followed by necrosis in both HK1 and CNE2. Western blot experiments confirmed that cytotoxic killing of HK1 and CNE2 by quercetin was mediated by the up-regulation of pro-apoptotic protein Bad, caspase-3 and -7, resulting in cell death by apoptosis. Our study demonstrates that quercetin inhibits cell growth of nasopharyngeal carcinoma cell lines HK1 and CNE2 by inhibiting cell cycle progression to S phase. Quercetin is also able to induce apoptosis and necrosis in these cells regardless of the p53 status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention
Ramos, S. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.11.004 · Cited by 617
Flora, S. J. S. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.4.9112 · Cited by 616
Effects of low dose quercetin: Cancer cell‐specific inhibition of cell cycle progression
Jeong, J., An, J. Y., Kwon, Y. T., Rhee, J. G., & Lee, Y. J. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21977 · Cited by 380
Granado-Serrano, A. B., Martiín, M. A., Bravo, L., Goya, L., & Ramos, S. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.11.2715 · Cited by 374
Flavonoids and Cancer Prevention: A Review of the Evidence
Romagnolo, D. F., & Selmin, O. I. (2012) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2012.702534 · Cited by 354
Chou, C.-C., Yang, J.-S., Lu, H.-F., Ip, S.-W., Lo, C., Wu, C.-C., Lin, J.-P., Tang, N.-Y., Chung, J.-G., Chou, M.-J., et al. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-0808-y · Cited by 310
Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential
Kashyap, D., Garg, V. K., Tuli, H. S., Yerer, M. B., Sak, K., Sharma, A. K., Kumar, M., Aggarwal, V., & Sandhu, S. S. (2019) · Biomolecules · doi:10.3390/biom9050174 · Cited by 285
“Similarly, quercetin enhanced the expression of retinoblastoma (Rb) gene in nasopharyngeal carcinoma cells HK1 and CNE2 and blocked the cell cycle in the G2/M phase [83].”
BackgroundTavsan, Z., & Kayali, H. A. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109004 · Cited by 190
Kuo, P.-C., Liu, H.-F., & Chao, J.-I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407985200 · Cited by 190
Hsu, C., & Yen, G. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600040 · Cited by 165
Yang, J.-H., Hsia, T.-C., Kuo, H.-M., Chao, P.-D. L., Chou, C.-C., Wei, Y.-H., & Chung, J.-G. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005280 · Cited by 165
Park, J. H., Noh, S. M., Woo, J. R., Kim, J. W., & Lee, G. M. (2016) · Biotechnology Journal · doi:10.1002/biot.201500327 · Cited by 81
Metadata
- Authors
- Ong, C., Tran, E., Nguyen, T., Ong, C., Lee, S., Lee, J., Ng, C., Leong, C., & Huynh, H.
- Venue
- Oncology Reports
- Publisher
- Spandidos Publications
- Published
- 2004-03-01
- Volume
- 11
- Issue
- 3
- Pages
- 727-33
- ISSN
- 1021-335X (ISSN-L)
- 1791-2431
- OpenAlex
- W2078899739
- Cited by
- 138
- References
- 0
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.